**Core Concept**
The complement system, specifically the alternative pathway, plays a crucial role in the innate immune response. Serum C3 is a critical component, acting as a central molecule in the complement cascade. Low levels of C3 can indicate an underlying immune disorder.

**Why the Correct Answer is Right**
Persistent low levels of C3 can be seen in conditions where the complement system is dysregulated, such as in autoimmune diseases like systemic lupus erythematosus (SLE). In SLE, the immune system produces antibodies against the C3 convertase enzyme, leading to its consumption and subsequent low levels of C3. This results in impaired complement-mediated opsonization and phagocytosis, contributing to the disease's pathogenesis.

**Why Each Wrong Option is Incorrect**
**Option A:**
Hemolytic uremic syndrome (HUS) is characterized by low levels of C3 due to the formation of C3 convertase, which is not a persistently low state of C3, rather an acute consumption.

**Option B:**
Rapidly progressive glomerulonephritis (RPGN) may present with low levels of C3 due to the activation of the complement system. However, the C3 levels may normalize as the disease progresses.

**Option C:**
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder characterized by bone marrow failure, hemolytic anemia, and the presence of blood clots. PNH is associated with low levels of C3 due to the absence of CD55 and CD59 on the surface of red blood cells, making them susceptible to complement-mediated lysis.

**Clinical Pearl / High-Yield Fact**
In patients with SLE, low levels of C3 are associated with a higher risk of renal involvement and disease flares.

**Correct Answer: B.**